The company now expects at least $4.90 per share in adjusted earnings in 2022, compared with at least $4.70 forecast earlier.
(Reporting by Leroy Leo and Amruta Khandekar in Bengaluru; Editing by Maju Samuel and Sriraj kalluvila)
(Reuters) - Abbott Laboratories on Wednesday raised its annual earnings forecast following strong demand for its medical devices and diagnostics products.
The company now expects at least $4.90 per share in adjusted earnings in 2022, compared with at least $4.70 forecast earlier.
(Reporting by Leroy Leo and Amruta Khandekar in Bengaluru; Editing by Maju Samuel and Sriraj kalluvila)
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
104.1 USD | -0.74% | -0.62% | 181B | ||